Cardiac failure incurs a major economic and social burden on the United States populace, while also providing a distinct technical challenge since options for treating this condition remain highly limited. In ischemic cardiomyopathy ventricular wall thinning is coupled with dilation of the ventricular cavity. This remodeling process is associated with elevated ventricular wall stress that positively drives the thinning and dilation process towards end-stage heart failure. In the proposed work we will create novel designs for injectable biomaterials to bulk the thinning, post-infarct cardiac wall, reducing elevated wall stress, and potentially improving cardiac remodeling outcomes. The design objectives include synthesizing materials with tensile properties suitable for reducing wall stresses, degradation properties that maintain the hydrogel in the infarcted wall for a period of months during the remodeling process, and drug delivery properties that allow the controlled release of multiple growth factors that may stimulate beneficial cardiac remodeling. We will evaluate 3 distinct hydrogel designs with increasing complexity, utilizing both rat and porcine models of ischemic cardiomyopathy and a minimally invasive robotic technology (the HeartLander device) designed to effectively deliver the targeted hydrogel injections. The project specific aims are to: 1) Evaluate the functional and histopathologic effect of injecting the thermoresponsive hydrogel, poly(NIPAAm-co-acrylic acid-co-2-hydroxyethyl methacrylate-poly(trimethylene carbonate) into the central and border regions of a myocardial infarct in a porcine model for ischemic cardiomyopathy using a modified HeartLander minimally invasive robotic system. 2) Evaluate the functional and histopathologic effect of injecting the thermoresponsive hydrogel, poly(NIPAAm-co-HEMA-co-polylactide-methacrylate) into the central and border regions of a myocardial infarct in rat and then porcine (with HeartLander) models for ischemic cardiomyopathy. Hydrogel design optimization will be based on in vitro and rat in vivo results. 3) Develop and characterize the thermoresponsive hydrogel poly (NIPAAm-co-N-hydroxysuccinimide- methacrylate-co-HEMA-co-MAPLA) and the ability of this gel to deliver bFGF in vitro, as well as the ability to load this gel with microspheres containing IGF-1 for more extended controlled release. 4) Evaluate the functional and histopathologic effect of injecting growth factor loaded hydrogel from Aim #3, into infarcted myocardium in rat and porcine (with HeartLander) models for ischemic cardiomyopathy. Relevance: Once the early period following a heart attack passes, there are limited options for treating the heart failure that can develop. At the end of the proposed funding period we will have developed innovative injectable materials to treat heart failure following a heart attack as well as a robotic delivery system to allow material delivery in a manner that would minimize patient discomfort, complications and recovery time.

Public Health Relevance

It is estimated that 785,000 Americans will have a heart attack annually, and many of those who survive will ultimately face deteriorating function of their heart leading to later death. This research seeks to develop an approach where a gel-like material is injected into the heart after a heart attack to prevent the deterioration in heart function. This gel is being designed to protect the heart mechanically from further damage after the heart attack and to help stimulate the heart to heal itself.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL105911-01
Application #
8022517
Study Section
Biomaterials and Biointerfaces Study Section (BMBI)
Program Officer
Lundberg, Martha
Project Start
2011-01-01
Project End
2015-11-30
Budget Start
2011-01-01
Budget End
2011-11-30
Support Year
1
Fiscal Year
2011
Total Cost
$360,270
Indirect Cost
Name
University of Pittsburgh
Department
Surgery
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Zhu, Yang; Wood, Nathan A; Fok, Kevin et al. (2016) Design of a Coupled Thermoresponsive Hydrogel and Robotic System for Postinfarct Biomaterial Injection Therapy. Ann Thorac Surg 102:780-6
Yoshizumi, Tomo; Zhu, Yang; Jiang, Hongbin et al. (2016) Timing effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarction. Biomaterials 83:182-93
Zhu, Yang; Jiang, Hongbin; Ye, Sang-Ho et al. (2015) Tailoring the degradation rates of thermally responsive hydrogels designed for soft tissue injection by varying the autocatalytic potential. Biomaterials 53:484-93
Nelson, Devin M; Hashizume, Ryotaro; Yoshizumi, Tomo et al. (2014) Intramyocardial injection of a synthetic hydrogel with delivery of bFGF and IGF1 in a rat model of ischemic cardiomyopathy. Biomacromolecules 15:1-11
Costanza, Adam D; Wood, Nathan A; Passineau, Michael J et al. (2014) A parallel wire robot for epicardial interventions. Conf Proc IEEE Eng Med Biol Soc 2014:6155-8
Wood, Nathan A; Waugh, Kevin; Liu, Tian Yu Tommy et al. (2013) Space-Time Localization and Registration on the Beating Heart. Rep U S 2012:3792-3797
Tortora, Giuseppe; Glass, Paul; Wood, Nathan et al. (2012) Investigation of bioinspired gecko fibers to improve adhesion of HeartLander surgical robot. Conf Proc IEEE Eng Med Biol Soc 2012:908-11
Wood, Nathan A; Liu, Tian Yu Tommy; Waugh, Kevin et al. (2012) Towards localizing on the surface of the beating heart. Conf Proc IEEE Eng Med Biol Soc 2012:1413-6
Patronik, N A; Zenati, M A; Riviere, C N (2012) A Study Ex Vivo of the Effect of Epicardial Fat on the HeartLander Robotic Crawler. IFMBE Proc 37:227-230
Wood, Nathan A; Schwartzman, David; Zenati, Marco A et al. (2012) Toward Onboard Estimation of Physiological Phase for an Epicardial Crawling Robot. Proc IEEE RAS EMBS Int Conf Biomed Robot Biomechatron 2012:6290716

Showing the most recent 10 out of 13 publications